| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT01080391 |
| P6099 | clinical trial phase | phase III clinical trial | Q42824827 |
| P17 | country | Canada | Q16 |
| Hungary | Q28 | ||
| Spain | Q29 | ||
| United States of America | Q30 | ||
| Belgium | Q31 | ||
| Sweden | Q34 | ||
| Poland | Q36 | ||
| Italy | Q38 | ||
| Austria | Q40 | ||
| Greece | Q41 | ||
| Netherlands | Q55 | ||
| France | Q142 | ||
| United Kingdom | Q145 | ||
| Romania | Q218 | ||
| Bulgaria | Q219 | ||
| Germany | Q183 | ||
| Serbia | Q403 | ||
| Israel | Q801 | ||
| P582 | end time | 2014-06-16 | |
| P1050 | medical condition | multiple myeloma | Q467635 |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 792 | |
| P4844 | research intervention | (RS)-cyclophosphamide | Q408524 |
| (RS)-lenalidomide | Q425681 | ||
| P6153 | research site | Stanford University | Q41506 |
| New York University | Q49210 | ||
| McGill University | Q201492 | ||
| University of Barcelona | Q219615 | ||
| Tel Aviv University | Q319239 | ||
| University of Gothenburg | Q371522 | ||
| Katholieke Universiteit Leuven | Q833670 | ||
| Mayo Clinic | Q1130172 | ||
| University of Pécs | Q1187444 | ||
| Baylor University | Q812573 | ||
| Fred Hutchinson Cancer Research Center | Q1452369 | ||
| Rush University Medical Center | Q1535116 | ||
| University Hospital Muenster | Q1748138 | ||
| Rabin Medical Center | Q2071553 | ||
| University of Texas Southwestern Medical Center | Q2725999 | ||
| AZ Sint-Jan | Q2804407 | ||
| Kaplan Medical Center | Q2890053 | ||
| Barts Health NHS Trust | Q4865798 | ||
| Hackensack University Medical Center | Q5637237 | ||
| Hospital Universitario Miguel Servet | Q5902953 | ||
| University of Texas at Houston Police Department | Q7896459 | ||
| Vancouver General Hospital | Q7914187 | ||
| University Hospital Hradec Kralove | Q17277118 | ||
| University Hospital Olomouc | Q26935593 | ||
| Krankenhaus Nordwest | Q30264419 | ||
| Colorado Blood Cancer Institute | Q43896855 | ||
| Salamanca University Hospital | Q87762406 | ||
| P580 | start time | 2010-07-14 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma |
Search more.